Evidence map›Paper›PMID 39771104›Full record

ArticleToxics2024

Assessment of Cytotoxicity and Genotoxicity of Plasma-Treated Perfluorooctanesulfonate Containing Water Using In Vitro Bioassays.

Markus Windisch, Roman Klymenko, Hannah Grießler, Clemens Kittinger

Abstract read
In one paragraph

Article in Toxics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Markus WindischDiagnostic and Research Institute of Hygiene, Microbiology and Environmental Medicine, Diagnostic and Research Center for Molecular Biomedicine, Medical University of Graz, 8010 Graz, Austria.
Roman KlymenkoWetsus, European Centre of Excellence for Sustainable Water Technology, 8911 MA Leeuwarden, The Netherlands.ORCID 0009-0002-2351-8550
Hannah GrießlerDiagnostic and Research Institute of Hygiene, Microbiology and Environmental Medicine, Diagnostic and Research Center for Molecular Biomedicine, Medical University of Graz, 8010 Graz, Austria.
Clemens KittingerDiagnostic and Research Institute of Hygiene, Microbiology and Environmental Medicine, Diagnostic and Research Center for Molecular Biomedicine, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0001-8472-2155

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The contamination of ground and surface waters with per- and polyfluoroalkyl substances (PFASs) is of major concern due to their potential adverse effects on human health. The carbon-fluorine bond makes these compounds extremely stable and hardly degradable by natural processes. Therefore, methods for PFAS removal from water are desperately needed. In this context, plasma treatment of water has been proposed as an effective method with reported removal rates exceeding 90%. However, the high reactivity of plasma discharge results in the formation of many reactive species, like radicals, ozone, or even solvated electrons, which lead to a complex reaction cascade and, consequently, to the generation of a wide variety of different chemical products. The toxicological properties of these PFAS breakdown products are largely unknown. The present study focuses on a toxicological assessment of PFAS-containing plasma-treated water samples. Aqueous solutions of long-chain perfluorooctanesulfonate (PFOS) were treated with various plasma-atmospheric regimes. Subsequently, plasma-treated water samples were subjected to in vitro bioassays. Cytotoxicity and genotoxicity were assessed with the MTS assay using human liver cells (HepG2) and the Ames MPF

Indexed as

cytotoxicitygenotoxicityPFASplasma treatment

Identifiers

PMID39771104
PMCPMC11728540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.